Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
310 GBX | 0.00% | +6.90% | +9.54% |
04-26 | EU Panel Backs Approval of Takeda’s Colorectal Cancer Drug | MT |
04-26 | Hutchmed notes CHMP's positive opinion for fruiquintinib approval | AN |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+9.54% | 3.31B | |
+26.57% | 681B | |
+21.85% | 556B | |
-4.91% | 361B | |
+17.15% | 325B | |
+5.34% | 285B | |
+13.68% | 235B | |
+3.65% | 199B | |
-11.12% | 189B | |
-4.12% | 157B |
- Stock Market
- Equities
- HCM Stock
- News HUTCHMED (China) Limited
- Hutchmed Presents Clinical Trials Data for Combination Cancer Treatment